Editorial (Hot Topic: PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer)

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|3|233-233

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.3, 2013-03, pp. : 233-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer)

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 117-120

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 188-204

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

By  

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4433-4447

Bentham Science Publishers

Access to resources Recommend Favorite

Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3070-3080

Bentham Science Publishers

Access to resources Recommend Favorite